NCT01064726View on ClinicalTrials.gov

A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Allergic Rhinitis
Interventions
DRUG

Ibuprofen

800 mg oral

DRUG

Fluticasone propionate

200 mcg intra-nasal

DRUG

Placebo

Placebo

Trial Locations (1)

68131

Pfizer Investigational Site, Omaha

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01064726 - A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response. | Biotech Hunter | Biotech Hunter